MYCOPLASMA EXPERIENCE LIMITED
Significant control: George David Windsor (50–75%), Helena Mary Windsor (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Mycoplasma Experience Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Mycoplasma Experience Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
MYCOPLASMA EXPERIENCE LIMITED is an active private limited company (company number 02289379) incorporated on 24 August 1988, registered in Surrey. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 August 2025, showing net assets of £717k and cash of £554k, with 5 employees on average. Net assets rose 16% on the prior period (£615k).
By net assets it sits in the top quarter of 54 comparable companies in Surrey (median £1,000, upper quartile £121k).
Ownership and control
- Mr George David Windsor
- owns 50–75% of shares
- holds 50–75% of voting rights
- Mrs Helena Mary Windsor
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 24 August 198838 yrs ago
- Next accounts due
- 31 May 2027in 216 days
- Confirmation statement due
- 7 September 2027in 315 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 August 2025 | £717k | £554k | — | — | — | — | 5 |
| 31 August 2024 | £615k | £450k | — | — | — | — | 5 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets above zeroNet assets £716,783 at 31 August 2025
- Net assets up 10% or more on the prior period+16.5% vs prior period
- Cash at bank of £50,000 or moreCash £554,060
- Incorporated five or more years agoIncorporated 24 August 1988
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 315 days
- Next accounts duein 216 days
- Accounts period endNet assets £717k · small accounts
- Accounts period endNet assets £615k · small accounts
- Incorporated
Similar companies in Surrey
- THERADEX (EUROPE) LIMITEDRedhill · inc. Apr 1992
- BIOCHEK (UK) LIMITEDGuildford · inc. Jul 1994
- IVY MEDICAL CHEMICALS DEVELOPMENT LIMITEDGodalming · inc. Sept 1997
- FUTURA MEDICAL DEVELOPMENTS LIMITEDGuildford · inc. Oct 1997
- MEDPHARM LIMITEDGuildford · inc. Jun 1999
- THE BRYANSTON TECHNOLOGY GROUP LTDGodalming · inc. Oct 2001
All companies incorporated on 24 August 1988 · in Aug 1988.
Reminders for MYCOPLASMA EXPERIENCE LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.